- Q1 2024 Nanobiotix SA Earnings Call TranscriptMay 22, 2024€5.41 (-13.93%)Earnings
- Nanobiotix SA 65th ASTRO Annual Meeting 2023 TranscriptOct 05, 2023
- Half Year 2023 Nanobiotix SA Earnings Call TranscriptSep 27, 2023€8 (+0.38%)Earnings
- Nanobiotix SA at HC Wainwright Investment Conference - New York TranscriptSep 11, 2023
- Nanobiotix SA License Agreement with Janssen Briefing TranscriptJul 10, 2023
- Q4 2022 Nanobiotix SA Earnings Call TranscriptApr 25, 2023€2.5 (-27.26%)Earnings
- Nanobiotix SA at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 01, 2022
- Nanobiotix SA at Jefferies London Healthcare Conference TranscriptNov 15, 2022
- Q3 2022 Nanobiotix SA Earnings Call TranscriptNov 10, 2022€3.68 (-1.87%)Earnings
- Q2 2022 Nanobiotix SA Earnings Call TranscriptSep 29, 2022€3.5 (-0.43%)Earnings
- Nanobiotix SA at UBS Global Healthcare Conference TranscriptMay 23, 2022
- Q1 2022 Nanobiotix SA Earnings Call TranscriptMay 19, 2022€5.18 (+0.58%)Earnings
- Q4 2021 Nanobiotix SA Earnings Call TranscriptMar 31, 2022Earnings
Nanobiotix SA at HC Wainwright Investment Conference - New York Transcript
Greetings, and thanks for joining us to have a conversation with Laurent Levy, CEO of Nanobiotix. Nanobiotix is developing a radio enhancer, NBTXR3, which is hafnium oxide nanoparticles that can induce radiotherapy upon injecting into the tumor. The drug has received CE mark in 2019. Recently the company forged a global co-development and co-commercialization agreement with Janssen Pharmaceuticals.
To learn more about the drug, the co-development agreement, and the clinical development strategy, I welcome Laurent to the fireside chat. Laurent, glad to see you and appreciate you accepting our invitation to talk to our audience.
Questions & Answers
So Laurent, when you started the company back in 20 years ago, so what was the problem that you were trying to solve? And since you have -- since then, what sort of achievements has the company made?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)